Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome
scientific article published on 05 June 2013
Author/s
author: Gianluca Caridi, Andrea Pasini, Davide Martorana, Augusto Vaglio, Giovanni Montini, Alberto Edefonti, Gian Marco Ghiggeri, Monica Bodria, Francesco Scolari, Pietro Ravani, Antonello Pani, Corrado Murtas, Mirco Belingheri, Luciana Ghio, Changli Wei, Sandra Merscher-Gomez
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.